Bioxel, a company which manufactures and markets taxane active pharmaceutical ingredients (APIs) used in chemotherapeutic drugs, has turned to two contract manufacturing companies to scale up production.

In-PharmaTechnologist.com (http://www.in-pharmatechnologist.com/news/ng.asp?n=68190-bioxel-taxanes-paclitaxel-docetaxel)